Search
Search Results
##search.searchResults.foundPlural##
-
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1284PDF: 509HTML: 8306 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2931PDF: 800HTML: 1310Blood Count trend before and during lenalidomide treatment: 206Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 214 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1033PDF: 559HTML: 743 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1441PDF: 621Suppl. Files: 379HTML: 176 -
-
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1505PDF: 970HTML: 256 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3789PDF: 1342HTML: 2169Fig.1: 238Fig. 2: 233 -
THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis
1510PDF: 1482PDF: 1052HTML: 233 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1398PDF: 1011HTML: 500 -
ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
94PDF: 77Suppl. Files: 14Html: 13Html Suppl. Files: 12 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1811PDF: 835HTML: 303 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2248PDF: 1629HTML: 685 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
3040PDF: 1156HTML: 4678 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1723PDF: 676HTML: 2445 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4878PDF: 1608HTML: 2269Untitled: 256Untitled: 270Untitled: 289Untitled: 240Untitled: 257 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1197PDF: 1033Suppl. Files: 481HTML: 359 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3771PDF: 1734HTML: 2697 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1197PDF: 628Suppl. Files: 145HTML: 486 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3296PDF: 1151HTML: 1922 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4488PDF: 1804HTML: 1124







